Investigative Summary: Findings of Misconduct by a then Senior Official with the Drug Enforcement Administration for Misuse of Official Position Related to Giving Preferential Treatment to a Pharmaceutical Company, and Related Misconduct
- NARA ID
- investigative-summary-findings-misconduct-then-senior-official-drug-enforcement
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Investigation
- Released
- 2021-12-02
- Slug
- doj-oig-investigative-summary-findings-misconduct-then-senior-official-drug-enforcement
- Indexed
- 2026-04-27 05:02:45
More from DOJ OIG — Drug Enforcement Administration
- Investigative Summary: Findings of Misconduct by a then Drug Enforcement Administration Assistant Special Agent in Charge for Having an Inappropriate, Intimate Relationship with a Subordinate, Obstruction, Lack of Candor, and Related Misconduct
- Audit of the Drug Enforcement Administration's Income-Generating, Undercover Operations
- Bonuses and Other Favorable Personnel Actions for Drug Enforcement Administration Employees Involved in Alleged Sexual Misconduct Incidents Referenced in the OIG's March 2015 Report
- A Review of the Drug Enforcement Administration's Use of Administrative Subpoenas to Collect or Exploit Bulk Data (Revised March 2025)
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration Special Agent in Charge for Installing and Remotely Monitoring an Unauthorized Personally-Owned Camera in the DEA Office
- Review of the Drug Enforcement Administration's Regulatory and Enforcement Efforts to Control the Diversion of Opioids
Browse all 60 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.